The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list ...

The FDA declared the end to shortages of Zepbound and Mounjaro. That could mean new restrictions on pharmacies making ...

Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S., ...

"GMA" shares an exclusive look inside the lab of the maker of such drugs as Mounjaro and Zepbound to show what it's doing to ...

The U.S. Food and Drug Administration said Eli Lilly's diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage, signaling that the company has succeeded in expanding ...

The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage, signaling that the company has succeeded in expanding ...

"The quality of your friendships is a key factor for your well-being, especially if you're single," a team led by Lisa Walsh, ...

Investors in healthcare and biotech stocks suffered over recent years but with companies like Eli Lily and Novo Nordisk performing well some experts believe the market has turned ...

John Sloat as vice president of advancement and Dr. Emi Kreklau as the executive director of the Catalyst Corridor, a project funded by the Lilly Endowment College and Community Collaboration ...